China Announces Plans to Facilitate Foreign Investments in its Biopharma Industry

China’s State Council has increased its effort to attract foreign direct capital investments, especially for biotech investors. The government has issued a 24-point list of guidelines that establishes the areas of major focus where investors are likely to find opportunities. It specifically singled out biotechnology investments as a major goal, promising to facilitate investments, issue business visas and offer tax incentives for foreign businesses with an aim to “improve the business environment for foreign investors and boost foreign direct investment (FDI).” At the same time, the US is restricting some China investments, though its emphasis is on national security. More details....

Share this with colleagues: